Digital and Crypto Developments
HIVE (HIVE) has surpassed the 12 EH/s milestone and now boasts a $250 million annual run rate revenue, fueled by its expansion in Paraguay, as detailed in the full report.
MicroCloud Hologram Inc. (HOLO) announced it has purchased up to $200 million in Bitcoin and cryptocurrency-related securities derivatives, currently reporting a cumulative investment income of $34.02 million. Investors can review the full details.
DeFi Dev Corp (DFDV) and Switchboard have joined forces to advance RWA oracle infrastructure on Solana, aiming to set new standards for decentralized finance, as explained in the detailed update.
Earnings & Financial Results
SemiLEDs (LEDS) reported its Q3 fiscal year 2025 financial results, offering essential insights into its performance and growth trajectory. The complete figures are available in the full release.
Nextdoor (KIND), now trading as NXDR following a ticker change, released its second quarter 2025 financial results along with an announced conference call date. More details are provided in the official update.
Central Garden & Pet (CENTA) raised its fiscal 2025 non-GAAP EPS outlook, now expecting EPS of approximately $2.60, an indicator of strengthening fundamentals as noted in the detailed report.
Corporate Finance & Strategic Moves
Hafnia (HAFN) secured a $715 million revolving credit facility, positioning the shipping and logistics company for robust operational support, as highlighted in their statement.
Ryde (RYDE) is expanding its operations to capture Singapore’s ultra-premium electric vehicle market—a strategic move that could redefine its competitive positioning, as detailed in the update.
Houston American Energy Corp. (HUSA) bolstered its strategic financing by securing a $100 million equity line of credit along with $5 million for acquiring a Texas Gulf Coast development site. More details are available in their equity line report and financing update.
ReElement Technologies (AREC) launched an innovative urban mining-to-magnet tolling service that achieves over 99.5% separation of rare earth oxides—a disruptive breakthrough detailed in the full report.
Schneider (SNDR) reported faster transit times and a remarkable 99.98% security rate on its Mexico cross-border route with CPKC, an operational improvement that underscores its efficiency, as outlined in the update.
Boqii Holding Limited (BQ) announced the effectiveness of its substitution listing along with a 1-for-160 reverse split, actions that are set to reshape its capital structure, as detailed in the release.
ESS (GWH) secured a $31 million insider-led funding package to continue executing its strategic shift while also securing its first Energy Base Order, as reported in the press release.
TDS (TDS) marks a significant regulatory milestone as the US Department of Justice Antitrust Division has closed its investigation into the proposed transaction involving T-Mobile and UScellular, detailed in the official announcement.
Walgreens Boots Alliance (WBA) witnessed overwhelming shareholder approval of its transaction with Sycamore Partners, a move that could reshape its market strategy; further information is available in the transaction update.
ZenaTech (ZENA) responded to a 'Unleashing U.S. Military Drone Dominance' memo with notable strategic adjustments for its ZenaDrone platform—a reaction that may influence its positioning in the defense tech landscape, as explained in the full report.
Braskem (BAK) is expanding its fleet by introducing the vessel Brave Future, a move that reinforces its global logistics strategy and bolsters operational capacity, as detailed in the announced update.
Eaton Vance Municipal Bond Fund (EIM) announced a tender offer to purchase up to 5% of its outstanding shares, a strategic step that could impact shareholder value, as outlined in the official release.
Healthcare & Life Sciences
Milestone Pharmaceuticals (MIST) reached a key regulatory milestone with FDA acceptance of its response to the CRL for CARDAMYST™ (etripamil) nasal spray, while also pricing a $52.5 million public offering, consolidating its funding strategy. Full details are available in the announcement and detailed release.
Capricor Therapeutics (CAPR) provided an update on regulatory progress regarding its Deramiocel BLA for Duchenne Muscular Dystrophy—a key step toward potential approval, detailed in the release.
MiNK Therapeutics (INKT) announced the publication documenting complete remission following its allogeneic iNKT cell therapy in metastatic testicular cancer, marking a breakthrough now detailed in the full report.
BriaCell (BCTX) reported that its Bria-IMT™ therapy demonstrates a survival advantage over Trodelvy® and a control group in metastatic breast cancer, as highlighted in the study update.
CEL-SCI (CVM) is set to sign a partnership agreement with a leading Saudi Arabian pharma company for Multikine in the treatment of head and neck cancer—a strategic deal detailed in the announcement.
Immix Biopharma (IMMX) announced its class-leading safety profile, paving the way for potential future indication expansion, as outlined in the report.
Technology & Cybersecurity
Check Point Software Technologies (CHKP) has been named a leader in Zero Trust Platforms for Q3 2025, a recognition that underscores its robust cybersecurity framework and market leadership, as reported in the evaluation update.
